Literature DB >> 8186888

Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas.

Y Kikuchi1, T Kishi, M Suzuki, M Furusato, S Aizawa.   

Abstract

p53 tumour suppressor gene mutations were studied in 118 renal cell carcinomas using paraffin-embedded surgical material. Optimal results were obtained with analysis of exon lengths between 150 and 200 base pairs for polymerase chain reaction. Single strand conformation polymorphism and sequencing analysis revealed only two point mutations (2/118, 2%): one involving codon 135; TGC-->TTC (cysteine-->phenylalanine) and the other codon 175; CGC-->CAC (arginine-->histidine). Both of these cases were classified as granular cell subtype on microscopic observation. The data suggest that the p53 tumour suppressor gene is not related to tumour initiation, promotion, or progression of renal cell carcinomas. However, there is the possibility that granular cell type carcinomas may have a different genetic background from clear cell type renal neoplasms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8186888     DOI: 10.1007/bf00194605

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  An efficient method for the extraction of DNA from formalin-fixed, paraffin-embedded tissue by sonication.

Authors:  M J Heller; L J Burgart; C J TenEyck; M E Anderson; T C Greiner; R A Robinson
Journal:  Biotechniques       Date:  1991-09       Impact factor: 1.993

Review 3.  p53 and human malignancies.

Authors:  V Rotter; M Prokocimer
Journal:  Adv Cancer Res       Date:  1991       Impact factor: 6.242

4.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Infrequent ras oncogene point mutations in renal cell carcinoma.

Authors:  D M Nanus; I R Mentle; R J Motzer; N H Bander; A P Albino
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

6.  Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.

Authors:  A Kovacs; S Storkel; W Thoenes; G Kovacs
Journal:  J Pathol       Date:  1992-07       Impact factor: 7.996

7.  Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type.

Authors:  A H van der Hout; E van den Berg; P van der Vlies; T Dijkhuizen; S Störkel; J W Oosterhuis; B de Jong; C H Buys
Journal:  Int J Cancer       Date:  1993-02-01       Impact factor: 7.396

8.  Chromosome 17p deletions and p53 mutations in renal cell carcinoma.

Authors:  R E Reiter; P Anglard; S Liu; J R Gnarra; W M Linehan
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

9.  Maintenance of p53 alterations throughout breast cancer progression.

Authors:  A M Davidoff; B J Kerns; J D Iglehart; J R Marks
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

10.  Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.

Authors:  O Ogawa; T Habuchi; Y Kakehi; M Koshiba; T Sugiyama; O Yoshida
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

View more
  5 in total

1.  Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.

Authors:  G Chemeris; A Loktinov; A Rempel; M Schwarz; P Bannasch
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas.

Authors:  H Sugo; S Takamori; K Kojima; T Beppu; S Futagawa
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 3.  p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?

Authors:  Aidan P Noon; Nikolina Vlatković; Radosław Polański; Maria Maguire; Howida Shawki; Keith Parsons; Mark T Boyd
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

4.  Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway.

Authors:  Haibiao Xie; Kaifang Ma; Kenan Zhang; Jingcheng Zhou; Lei Li; Wuping Yang; Yanqing Gong; Lin Cai; Kan Gong
Journal:  Cell Death Dis       Date:  2021-01-05       Impact factor: 8.469

5.  Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.

Authors:  Y Nishiyama; H Suwa; K Okamoto; M Fukumoto; H Hiai; S Toyokuni
Journal:  Jpn J Cancer Res       Date:  1995-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.